Babak Izadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Babak Izadi has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Sedigheh Khazaei
Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
5 shared publications- Parviz Mohajeri
Kermanshah Univ Med Sci, Sch Med, Dept Microbiol, Kermanshah, Iran
4 shared publications Soraya Sajadimajd
4 shared publications- Abbas Farahani
Molecular Medicine Research Center, Khomein University of Medical Sciences, Khomein, Iran
3 shared publications Seyed Hamid Madani
3 shared publications- Hamid Reza Mozaffari
Department of Oral and Maxillofacial Medicine, School of Dentistry, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 shared publications
Latest Publications
- 1 January 2019
- Published by Polaris in Clinical Cancer Investigation Journal
- Vol. 8  (5) , 177-181
The diagnostic value of kappa/lambda ratios determined by immunohistochemistry in the differentiation of plasma cell myeloma from reactive plasmacytosis
Context: Plasma cell myeloma (PCM) is the second-most common B-cell malignancy in western countries. In this disease, the bone marrow is infiltrated by monoclonal plasma cells, which may secrete immunoglobulin light chains. In this line, reactive plasma cells may infiltrate into the bone marrow that can lead to misdiagnosis of the disease. Aims: The purpose of this study was to determine monoclonality using immunohistochemistry (IHC) for kappa and lambda light chains in bone marrow biopsy (BMB) specimens. These findings may be useful in the differentiation of PCM from reactive plasmacytosis. Materials and Methods: In this study, BMB paraffin blocks from 90 patients including 45 cases of PCM and 45 patients with reactive plasmacytosis were collected at the pathology center of Imam Reza Hospital from 2006 to 2014. IHC staining for CD138 and Kappa-Lambda light chains were performed. Relative frequencies of Kappa to Lambda light chain positive cells were calculated. Statistical Analysis Used: The results were analyzed with spss16 and Rx64 3.1.2 software. Results: Strong Kappa staining was found in 37 of 45 PCM cases (82.2%), with the ratio of Kappa/Lambda>3 and eight other cases (17.8%) expressed Kappa/Lambda<0.48. In cases with reactive plasmacytosis, K/L ratio was 0.48≤ × ≤3. Sensitivity and specificity for the diagnosis of PCM versus reactive plasmacytosis were 100% and 97.8%, respectively. Conclusions: Results indicated that immunohistochemical staining of CD138, kappa, and lambda light chains could be considered as an assured and reliable assay for the diagnosis of monoclonal plasma cells and differentiating it from other hematological malignancies.
- 1 January 2019
- Published by Polaris in Clinical Cancer Investigation Journal
- Vol. 8  (5) , 177-181
The diagnostic value of kappa/lambda ratios determined by immunohistochemistry in the differentiation of plasma cell myeloma from reactive plasmacytosis
Context: Plasma cell myeloma (PCM) is the second-most common B-cell malignancy in western countries. In this disease, the bone marrow is infiltrated by monoclonal plasma cells, which may secrete immunoglobulin light chains. In this line, reactive plasma cells may infiltrate into the bone marrow that can lead to misdiagnosis of the disease. Aims: The purpose of this study was to determine monoclonality using immunohistochemistry (IHC) for kappa and lambda light chains in bone marrow biopsy (BMB) specimens. These findings may be useful in the differentiation of PCM from reactive plasmacytosis. Materials and Methods: In this study, BMB paraffin blocks from 90 patients including 45 cases of PCM and 45 patients with reactive plasmacytosis were collected at the pathology center of Imam Reza Hospital from 2006 to 2014. IHC staining for CD138 and Kappa-Lambda light chains were performed. Relative frequencies of Kappa to Lambda light chain positive cells were calculated. Statistical Analysis Used: The results were analyzed with spss16 and Rx64 3.1.2 software. Results: Strong Kappa staining was found in 37 of 45 PCM cases (82.2%), with the ratio of Kappa/Lambda>3 and eight other cases (17.8%) expressed Kappa/Lambda<0.48. In cases with reactive plasmacytosis, K/L ratio was 0.48≤ × ≤3. Sensitivity and specificity for the diagnosis of PCM versus reactive plasmacytosis were 100% and 97.8%, respectively. Conclusions: Results indicated that immunohistochemical staining of CD138, kappa, and lambda light chains could be considered as an assured and reliable assay for the diagnosis of monoclonal plasma cells and differentiating it from other hematological malignancies.
- Open Access
- 27 February 2018
- Published by DoNotEdit in Iranian Red Crescent Medical Journal
- Vol. 20  (2)
The Survey of Her2/neu Expression and It’s Correlation with Some Pathological Factors in Urothelial Bladder Tumors
Overexpression of human epidermal growth factor receptor 2 (Her2) protein has been shown in a variety of human malignant tumors. In some of these tumors, such as breast carcinoma, targeted anti-Her2 therapy has been considered as a promising therapeutic strategy.The aim of this analytic descriptive study was to evaluate the immunohistochemical expression of Her2 and its relation to grade and muscular invasion of urothelial bladder tumor.In this descriptive-analytic study, 179 paraffin-embedded tissue blocks from patients with urothelial bladder tumors were selected for immunohistochemistry (IHC) analysis using antibodies against Her2. IHC staining was evaluated according to the same criteria of breast carcinoma.Her2 overexpression was detected in 49 patients (27.4%) and was significantly associated with high tumor grade and bladder muscular involvement (P < 0.001).Her2/neu over expression is associated with aggressive behavior of urothelial bladder tumors. Assessment of Her2 status could be helpful to identify patients with a high probability of disease progression. Anti-Her2 therapy could be used in urothelial bladder cancers, however, this issue needs further studies.
- 27 February 2018
- Published by DoNotEdit in Iranian Red Crescent Medical Journal
- Vol. 20  (2)
Open AccessThe Survey of Her2/neu Expression and It’s Correlation with Some Pathological Factors in Urothelial Bladder Tumors
Overexpression of human epidermal growth factor receptor 2 (Her2) protein has been shown in a variety of human malignant tumors. In some of these tumors, such as breast carcinoma, targeted anti-Her2 therapy has been considered as a promising therapeutic strategy.The aim of this analytic descriptive study was to evaluate the immunohistochemical expression of Her2 and its relation to grade and muscular invasion of urothelial bladder tumor.In this descriptive-analytic study, 179 paraffin-embedded tissue blocks from patients with urothelial bladder tumors were selected for immunohistochemistry (IHC) analysis using antibodies against Her2. IHC staining was evaluated according to the same criteria of breast carcinoma.Her2 overexpression was detected in 49 patients (27.4%) and was significantly associated with high tumor grade and bladder muscular involvement (P < 0.001).Her2/neu over expression is associated with aggressive behavior of urothelial bladder tumors. Assessment of Her2 status could be helpful to identify patients with a high probability of disease progression. Anti-Her2 therapy could be used in urothelial bladder cancers, however, this issue needs further studies.
- 1 December 2017
- Published by Elsevier in Journal of Controlled Release
- Vol. 268, 259-268
Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis
- 1 December 2017
- Published by Elsevier in Journal of Controlled Release
- Vol. 268, 259-268
Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis
- 1 November 2017
- Published by Maad Rayan Publishing Company
- Vol. 14  (6) , 5047-5050
Association Between Human Papillomavirus and Transitional Cell Carcinoma of the Bladder
Purpose: Bladder carcinoma is one of the most common malignancies in worldwide. Among several risk factors, Human Papilloma Virus (HPV) have been presumed to play a causative role in the etiology of bladder cell carcinoma. The aim of this study was to evaluate the involvement of HPV infection in biopsy specimens of patients with transitional cell carcinoma at the west of Iran. Materials and methods: In this study, 97 biopsy specimens including 67 patients with transitional cell carcinoma (TCC) of bladder and 30 cases of control group with the mean age of 63 years' were studied using immunohistochemistry to identify HPV. Results: 22.4% of patients with TCC of bladder and 3.3% of control group were positive for HPV with a meaningful relation (P=.019). The prevalence of HPV was 4.3 fold higher in men than women. Most TCC patients belonged to grades II and III. Conclusion: Considering the higher incidence of HPV positivity in patients with TCC of bladder compared to control group, it seems to be a meaningful association between HPV infection and TCC of bladder, at least in the west of Iran.
- 1 November 2017
- Published by Maad Rayan Publishing Company
- Vol. 14  (6) , 5047-5050
Association Between Human Papillomavirus and Transitional Cell Carcinoma of the Bladder
Purpose: Bladder carcinoma is one of the most common malignancies in worldwide. Among several risk factors, Human Papilloma Virus (HPV) have been presumed to play a causative role in the etiology of bladder cell carcinoma. The aim of this study was to evaluate the involvement of HPV infection in biopsy specimens of patients with transitional cell carcinoma at the west of Iran. Materials and methods: In this study, 97 biopsy specimens including 67 patients with transitional cell carcinoma (TCC) of bladder and 30 cases of control group with the mean age of 63 years' were studied using immunohistochemistry to identify HPV. Results: 22.4% of patients with TCC of bladder and 3.3% of control group were positive for HPV with a meaningful relation (P=.019). The prevalence of HPV was 4.3 fold higher in men than women. Most TCC patients belonged to grades II and III. Conclusion: Considering the higher incidence of HPV positivity in patients with TCC of bladder compared to control group, it seems to be a meaningful association between HPV infection and TCC of bladder, at least in the west of Iran.
- Open Access
- 1 September 2017
- Published by Elsevier in New Microbes and New Infections
- Vol. 19, 117-120
Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
- 1 September 2017
- Published by Elsevier in New Microbes and New Infections
- Vol. 19, 117-120
Open AccessEvaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
- Open Access
- 6 February 2017
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 10  (3)
The Prevalence and Genotype Distribution of Human Papillomavirus Types in the General Female Population in West of Iran
Background: Human Papillomavirus (HPV) plays a necessary etiological role in cervical cancer, it is logical to use HPV as a marker for the early detection of cervical cancer and precancerous. Prevalence of HPV infection and HPV genotypes vary among different regions. Objectives: The aim of the present study was to investigate the frequency of HPV and its genotype distribution in cervical specimens of the patients who had attended to the pathology laboratories of Kermanshah, Iran. Methods: Cervical swaps, genital, and skin biopsy were obtained from each participant. DNA of HPV specimens were extracted using a genomics extraction kit. PCR amplification and genotyping were employed to investigate the presence of High-risk (HR) and Low-risk (LR) genotypes and also the types of HPV. Results: Human Papillomavirus was found in 62.1% of the samples obtained from the patients. Among the HR and LR types, HPV-6 was the major genotype 64.8%. Type 16 and 18 were the most frequent HR-HPV types (presented in 26% of the patient), followed by type 50s (24.7%), 45, 30s, and 11 (1.8% from each). Multiple HPV infections were presented in 40.7% of the positive genotyping specimens. Conclusions: In comparison with previous surveys done in other parts of Iran, we noticed higher frequency of HPV among the collected isolates and also the higher prevalence of HPV types 6, 16, 18, and 50s in this region of Iran. It seems that HPV vaccination as well as an organized prevention program can be safe and efficient to reduce HPV types. Keywords: Human Papillomavirus; HPV Genotypes; Multiple HPV Infections Prevalence
- 6 February 2017
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 10  (3)
Open AccessThe Prevalence and Genotype Distribution of Human Papillomavirus Types in the General Female Population in West of Iran
Background: Human Papillomavirus (HPV) plays a necessary etiological role in cervical cancer, it is logical to use HPV as a marker for the early detection of cervical cancer and precancerous. Prevalence of HPV infection and HPV genotypes vary among different regions. Objectives: The aim of the present study was to investigate the frequency of HPV and its genotype distribution in cervical specimens of the patients who had attended to the pathology laboratories of Kermanshah, Iran. Methods: Cervical swaps, genital, and skin biopsy were obtained from each participant. DNA of HPV specimens were extracted using a genomics extraction kit. PCR amplification and genotyping were employed to investigate the presence of High-risk (HR) and Low-risk (LR) genotypes and also the types of HPV. Results: Human Papillomavirus was found in 62.1% of the samples obtained from the patients. Among the HR and LR types, HPV-6 was the major genotype 64.8%. Type 16 and 18 were the most frequent HR-HPV types (presented in 26% of the patient), followed by type 50s (24.7%), 45, 30s, and 11 (1.8% from each). Multiple HPV infections were presented in 40.7% of the positive genotyping specimens. Conclusions: In comparison with previous surveys done in other parts of Iran, we noticed higher frequency of HPV among the collected isolates and also the higher prevalence of HPV types 6, 16, 18, and 50s in this region of Iran. It seems that HPV vaccination as well as an organized prevention program can be safe and efficient to reduce HPV types. Keywords: Human Papillomavirus; HPV Genotypes; Multiple HPV Infections Prevalence
- 1 January 2017
- Published by Medknow in Annals of Tropical Medicine and Public Health
- Vol. 10  (1) , 104-108
Frequency of class 2 integrons in multidrug-resistant Acinetobacter baumannii isolated from patients in West of Iran
- 1 January 2017
- Published by Medknow in Annals of Tropical Medicine and Public Health
- Vol. 10  (1) , 104-108
Frequency of class 2 integrons in multidrug-resistant Acinetobacter baumannii isolated from patients in West of Iran
- Open Access
- 19 December 2016
- Published by Wiley in Case Reports in Dentistry
- Vol. 2016, 1-5
Solitary Plasmacytoma in the Mandible Resembling an Odontogenic Cyst/Tumor
A 46-year-old male patient referred to Department of Oral Medicine, with the primary chief complaint of a painless swelling in the right side of mandibular. A panoramic radiograph revealed a well-defined, multilocular radiolucent bony lesion with thin and straight septa in the right side of mandible extending from distal of canine to mesial of third molar. Histological examination showed a solid proliferation of atypical plasmacytoid cells, which was indicative of plasmacytoma. A systemic workup for the final diagnosis was performed to rule out multiple myeloma.
- 19 December 2016
- Published by Wiley in Case Reports in Dentistry
- Vol. 2016, 1-5
Open AccessSolitary Plasmacytoma in the Mandible Resembling an Odontogenic Cyst/Tumor
A 46-year-old male patient referred to Department of Oral Medicine, with the primary chief complaint of a painless swelling in the right side of mandibular. A panoramic radiograph revealed a well-defined, multilocular radiolucent bony lesion with thin and straight septa in the right side of mandible extending from distal of canine to mesial of third molar. Histological examination showed a solid proliferation of atypical plasmacytoid cells, which was indicative of plasmacytoma. A systemic workup for the final diagnosis was performed to rule out multiple myeloma.
- 1 December 2016
- Vol. 17  (12) , 5223-5227
Comparison Between Two Detection Methods for HPV16,HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
- 1 December 2016
- Vol. 17  (12) , 5223-5227
Comparison Between Two Detection Methods for HPV16,HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
- Open Access
- 1 December 2016
- Vol. 17  (12) , 5223-5227
Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
Background: Cervical cancer is the second most common cancer among women in many populations. While the Pap smear is a well established screening test it suffers from both false-positive and false-negative results in diagnosis of cancers and precancerous states. In this study, immunocytochemistry of the P16 biomarker and HPV-PCR were compared for their diagnostic potential. Materials and methods: In the study, we obtained pairs of specimens from 45 women with cervical dysplasia. One sample was placed in a liquid-based solution, and processed for staining of sections with antibodies to P16. HPV-PCR was performed on the other and the results obtained were analyzed by T-test using SPSS v. 15. Results: Using HPV-PCR 71% of the samples were found to be infected with either HPV 16 or HPV 18, and the rate of infection did not have a statistically significant relationship with higher grades of dysplasia (p= 0.253). In contrast, with immunocytochemistry evaluation of P16, 64% of the specimens were positive, but the percentage of positive results significantly increased with higher grades of dysplasia (p= 0.0001). Conclusion: Employment of the P16 marker as an optional test might be preferable over HPV-PCR for cervical dysplasia in our geographical region.
- 1 December 2016
- Vol. 17  (12) , 5223-5227
Open AccessComparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology
Background: Cervical cancer is the second most common cancer among women in many populations. While the Pap smear is a well established screening test it suffers from both false-positive and false-negative results in diagnosis of cancers and precancerous states. In this study, immunocytochemistry of the P16 biomarker and HPV-PCR were compared for their diagnostic potential. Materials and methods: In the study, we obtained pairs of specimens from 45 women with cervical dysplasia. One sample was placed in a liquid-based solution, and processed for staining of sections with antibodies to P16. HPV-PCR was performed on the other and the results obtained were analyzed by T-test using SPSS v. 15. Results: Using HPV-PCR 71% of the samples were found to be infected with either HPV 16 or HPV 18, and the rate of infection did not have a statistically significant relationship with higher grades of dysplasia (p= 0.253). In contrast, with immunocytochemistry evaluation of P16, 64% of the specimens were positive, but the percentage of positive results significantly increased with higher grades of dysplasia (p= 0.0001). Conclusion: Employment of the P16 marker as an optional test might be preferable over HPV-PCR for cervical dysplasia in our geographical region.